CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $902,000 | -24.6% | 77,166 | -13.4% | 0.00% | – |
| Q2 2023 | $1,197,000 | -12.4% | 89,134 | +8.2% | 0.00% | – |
| Q1 2023 | $1,366,000 | -16.9% | 82,410 | -6.7% | 0.00% | – |
| Q4 2022 | $1,643,000 | +164.1% | 88,340 | +82.2% | 0.00% | – |
| Q3 2022 | $622,000 | +109.4% | 48,476 | +14.5% | 0.00% | – |
| Q2 2022 | $297,000 | -24.6% | 42,321 | -11.2% | 0.00% | – |
| Q1 2022 | $394,000 | -3.9% | 47,653 | -21.2% | 0.00% | – |
| Q4 2021 | $410,000 | +52.4% | 60,439 | +19.4% | 0.00% | – |
| Q3 2021 | $269,000 | -68.5% | 50,605 | -66.0% | 0.00% | – |
| Q2 2021 | $855,000 | +327.5% | 148,737 | +242.0% | 0.00% | – |
| Q1 2021 | $200,000 | +40.8% | 43,491 | +2.7% | 0.00% | – |
| Q4 2020 | $142,000 | -42.0% | 42,353 | -48.7% | 0.00% | – |
| Q3 2020 | $245,000 | -36.2% | 82,500 | -0.8% | 0.00% | – |
| Q2 2020 | $384,000 | +19.3% | 83,167 | -0.6% | 0.00% | – |
| Q1 2020 | $322,000 | +4.2% | 83,703 | +1.5% | 0.00% | – |
| Q4 2019 | $309,000 | -29.8% | 82,500 | -0.5% | 0.00% | – |
| Q3 2019 | $440,000 | +26.8% | 82,936 | -8.2% | 0.00% | – |
| Q2 2019 | $347,000 | -58.8% | 90,376 | -45.2% | 0.00% | – |
| Q1 2019 | $842,000 | +165.6% | 165,000 | -0.0% | 0.00% | – |
| Q4 2018 | $317,000 | -49.8% | 165,006 | -1.3% | 0.00% | – |
| Q3 2018 | $632,000 | +22.5% | 167,182 | +1.2% | 0.00% | – |
| Q2 2018 | $516,000 | +31.0% | 165,226 | +0.1% | 0.00% | – |
| Q1 2018 | $394,000 | -39.1% | 165,090 | -0.3% | 0.00% | – |
| Q4 2017 | $647,000 | +49.8% | 165,530 | -3.5% | 0.00% | – |
| Q3 2017 | $432,000 | -5.1% | 171,487 | +3.9% | 0.00% | – |
| Q2 2017 | $455,000 | +41.3% | 165,041 | +0.0% | 0.00% | – |
| Q1 2017 | $322,000 | +85.1% | 165,000 | -0.6% | 0.00% | – |
| Q4 2016 | $174,000 | -32.3% | 166,013 | -29.7% | 0.00% | – |
| Q3 2016 | $257,000 | +119.7% | 236,061 | +43.0% | 0.00% | – |
| Q2 2016 | $117,000 | +963.6% | 165,030 | +4284.4% | 0.00% | – |
| Q3 2015 | $11,000 | -42.1% | 3,764 | -17.9% | 0.00% | – |
| Q2 2015 | $19,000 | +171.4% | 4,587 | +186.7% | 0.00% | – |
| Q1 2015 | $7,000 | +16.7% | 1,600 | -20.0% | 0.00% | – |
| Q4 2014 | $6,000 | -14.3% | 2,000 | 0.0% | 0.00% | – |
| Q3 2014 | $7,000 | +40.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2014 | $5,000 | 0.0% | 2,000 | -2.7% | 0.00% | – |
| Q1 2014 | $5,000 | +25.0% | 2,056 | +2.8% | 0.00% | – |
| Q4 2013 | $4,000 | -33.3% | 2,000 | 0.0% | 0.00% | – |
| Q3 2013 | $6,000 | +200.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2013 | $2,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |